2FV.F SCANDIDOS AB (PUBL)
- Market cap
- EUR 677K
- P/E
- -
- P/B
- 0.17x
- ROE
- -58.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.
Is 2FV.F undervalued?
Graham numberThe Graham number of SCANDIDOS AB (PUBL) cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SCANDIDOS AB (PUBL) fundamental analysis
No fundamental analysis for SCANDIDOS AB (PUBL) yet.
SCANDIDOS AB (PUBL) stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SCANDIDOS AB (PUBL)
ScandiDos AB (publ), together with its subsidiaries, provides measurement phantoms and advanced software solutions in the United States, Europe, Asia, and internationally. The company offers Delta4 products comprising Delta4 Phantom+ and Delta4Phantom+MR; Delta4 HexaMotion; and Delta4Insight, Delta4DVH Anatomy, Delta4 Machine QA, and Delta4 Statistics Module for the quality assurance in advanced radiation therapy techniques, including VMAT, RapidArc, IMRT, and tomotherapy. I…
Full company profileSCANDIDOS AB (PUBL) financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
SCANDIDOS AB (PUBL) annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 57.7M | 61.6M | 60.4M | 61.8M | 54.2M | 29.0M |
| Gross Profit | 47.9M | 52.9M | 46.3M | 47.1M | 44.3M | 25.1M |
| Operating Income | -7.62M | -8.23M | -8.17M | -13.5M | -2.99M | -27.0M |
| EBITDA | - | -3.00M | -11.2M | 2.47M | -722K | -24.7M |
| Net Income | -7.34M | -9.12M | 327K | -14.6M | -3.44M | -27.7M |
| EPS | -0.18 | -0.20 | 0.01 | -0.26 | -0.06 | -0.39 |
| Balance Sheet | ||||||
| Total Assets | 66.2M | 72.4M | 81.5M | 73.4M | 66.0M | 72.1M |
| Total Liabilities | 29.0M | 30.8M | 37.2M | 28.4M | 24.3M | 24.9M |
| Shareholders' Equity | 37.2M | 41.7M | 44.3M | 45.0M | 41.7M | 47.2M |
| Cash & Short-term Investments | 6.24M | 3.55M | 1.53M | 10.1M | 4.36M | 16.0M |
| Cash Flow | ||||||
| Operating Cash Flow | 2.39M | -11.9M | 1.49M | -7.20M | -154K | 3.98M |
| Capital Expenditure | 4.71M | 4.41M | 2.94M | 2.23M | 3.89M | 4.26M |
| Free Cash Flow | -2.32M | -16.3M | -1.46M | -9.43M | -4.04M | -276K |
| Ratios | ||||||
| ROE | -19.7% | -21.9% | 0.7% | -32.6% | -8.2% | -58.8% |
| ROA | -11.1% | -12.6% | 0.4% | -20.0% | -5.2% | -38.4% |
| Net Profit Margin | -12.7% | -14.8% | 0.5% | -23.7% | -6.3% | -95.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
SCANDIDOS AB (PUBL) dividends
SCANDIDOS AB (PUBL) has not paid dividends in the last 7 fiscal years.
Who owns SCANDIDOS AB (PUBL)
- Insiders 73.43%
- Institutions 4.61%
- Public & others 21.96%
- Shares outstanding 71.3M
- Free float 38.0M
SCANDIDOS AB (PUBL) company profile
- Company name
- SCANDIDOS AB (PUBL)
- Ticker
- 2FV.F
- ISIN
- SE0005768124
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 25
- Fiscal year end
- April
- Address
- Uppsala Science Park, Uppsala, Sweden, 751 83
- Phone
- 46 1 84 72 30 30
- Website
- scandidos.com
About SCANDIDOS AB (PUBL)
ScandiDos AB (publ), together with its subsidiaries, provides measurement phantoms and advanced software solutions in the United States, Europe, Asia, and internationally. The company offers Delta4 products comprising Delta4 Phantom+ and Delta4Phantom+MR; Delta4 HexaMotion; and Delta4Insight, Delta4DVH Anatomy, Delta4 Machine QA, and Delta4 Statistics Module for the quality assurance in advanced radiation therapy techniques, including VMAT, RapidArc, IMRT, and tomotherapy. It also provides installation services, service agreements, and additional services. It sells its products through sales offices and distributors. ScandiDos AB (publ) was founded in 2001 and is headquartered in Uppsala, Sweden.
SCANDIDOS AB (PUBL) management
4- Mr. Olof StrandingChief Executive Officer · born 1975
- Ms. Henriette MunchChief Financial Officer · born 1980
- Mr. Daniel PedersonCTO & Quality Manager · born 1978
- Mr. Anders MurmanExecutive Officer · born 1967